For Investors

Press Releases

ReWalk Robotics Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

07/06/20

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , July 06, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 4,938,278 of the Company’s ordinary shares, at a

ReWalk Robotics Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

07/01/20

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , July 01, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with several institutional investors providing for the issuance of approximately 4,938,278

ReWalk Announces Publication of ReStore Powered Exo-Suit Clinical Study Results

06/22/20

Primary Study End Points of Device Safety and Feasibility Received Positive Results; Majority of Participants Experienced Clinically Meaningful Walking Speed Improvements MARLBOROUGH, Mass. , June 22, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a

ReWalk Robotics Finalizes U.S. Distribution Agreements for Two Additional Neuro Rehabilitation Product Lines

06/04/20

-- Additional Lines Expand Company’s Portfolio and Include Telehealth Capable Stroke Rehabilitation Devices as well as Clinic and Home Use Devices for Persons with Spinal Cord Injury -- MARLBOROUGH, Mass. , June 04, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk," “we” or

Centers for Medicare & Medicaid Services Issues Positive Preliminary Coding Decision for ReWalk Exoskeleton

06/02/20

New HCPCS Level II Code for Exoskeletons Would Be a Significant Step Towards Access to Exoskeletons for Individuals with Spinal Cord Injuries MARLBOROUGH, Mass. , June 2, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical

ReWalk Robotics Reports First Quarter 2020 Financial Results

05/28/20

— Q1 2020 Total Revenue of $0.8 million at a reduced level due to COVID-19 pandemic — — German coverage broadly expanded with social accident and statutory insurance —             —   Expanding our portfolio by offering two new product lines— MARLBOROUGH, Mass.

ReWalk Robotics to Report First Quarter 2020 Financial Results on May 28, 2020

05/26/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 26, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2020 financial results on Thursday, May 28, 2020 , before the U.S.

ReWalk Robotics Increases Focus on Telehealth Opportunities

05/19/20

Continuing collaboration with engineers at Harvard addresses telehealth needs for rehabilitation and physical therapy in wake of COVID-19 MARLBOROUGH, Mass. , May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable

ReWalk Robotics Increases Focus on Telehealth Opportunities

05/19/20

Continuing collaboration with engineers at Harvard addresses telehealth needs for rehabilitation and physical therapy in wake of COVID-19 MARLBOROUGH, Mass., May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable

ReWalk Announces Binding Offer to Deutsche Gesetzliche Unfallversicherung (DGUV) - German Social Accident Insurance

05/12/20

83 million Germans, covered for work and commuting-related accidents, have the opportunity to access ReWalk products if the requirements and personal suitability are met MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel and BERLIN , May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd.

ReWalk Enters Agreements with Leading German Insurers TK and DAK-Gesundheit to Provide Coverage of Robotic Exoskeletons for Individuals with Spinal Cord Injuries

04/23/20

Two National Insurers Representing More Than 16 Million Germans Will Supply Eligible Paralyzed Beneficiaries with ReWalk 6.0 Exoskeleton Devices MARLBOROUGH, Mass and BERLIN , April 23, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of

ReWalk Letter to Shareholders on COVID-19 and the Potential Impact on Operations

03/24/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , March 24, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) a global leader in Exoskeleton technology for community use and rehabilitation centers, today issued the following letter to shareholders: To All Shareholders: The